From: Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients
Multivariate
OR(95% CI)
P-value of CIA
Age
(≤40 y vs. >40 y*)
0.14(0.06-0.34)
<0.001
Chemotherapy
(FEC* vs. TE vs. NE)
0.51(0.30-0.84)
0.009
Tamoxifen use
(yes vs. no*)
3.69(1.54-8.83)
0.003